Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Kenski, J."'
Autor:
Beck JD; BioNTech SE, Mainz, Germany., Kenski J; BioNTech SE, Mainz, Germany., Perrone M; Immuno-Biotherapy of Melanoma and Solid Tumors Unit, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.; University Vita-Salute San Raffaele, Milan, Italy., Pocaterra A; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Honey K; American Association for Cancer Research, Philadelphia, Pennsylvania.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2024 Feb 02; Vol. 12 (2), pp. 144-148.
Autor:
Pataskar A; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Champagne J; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Nagel R; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kenski J; Division of Molecular Oncology and Immunology, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Laos M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Michaux J; Lausanne Branch, Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Pak HS; Lausanne Branch, Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Bleijerveld OB; NKI Proteomics facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mordente K; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Navarro JM; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Blommaert N; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Nielsen MM; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Lovecchio D; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Stone E; Department of Molecular Biosciences, University of Texas, Austin, TX, USA., Georgiou G; Department of Molecular Biosciences, University of Texas, Austin, TX, USA., de Gooijer MC; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Tellingen O; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Altelaar M; NKI Proteomics facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, The Netherlands., Joosten RP; Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Perrakis A; Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Olweus J; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Bassani-Sternberg M; Lausanne Branch, Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Peeper DS; Division of Molecular Oncology and Immunology, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Agami R; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. r.agami@nki.nl.; Erasmus MC, Department of Genetics, Rotterdam University, Rotterdam, The Netherlands. r.agami@nki.nl.
Publikováno v:
Nature [Nature] 2022 Aug; Vol. 608 (7922), pp. E20.
Autor:
Pataskar A; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Champagne J; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Nagel R; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kenski J; Division of Molecular Oncology and Immunology, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Laos M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Michaux J; Lausanne Branch, Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Pak HS; Lausanne Branch, Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Bleijerveld OB; NKI Proteomics facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mordente K; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Navarro JM; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Blommaert N; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Nielsen MM; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Lovecchio D; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Stone E; Department of Molecular Biosciences, University of Texas, Austin, TX, USA., Georgiou G; Department of Molecular Biosciences, University of Texas, Austin, TX, USA., de Gooijer MC; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Tellingen O; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Altelaar M; NKI Proteomics facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, The Netherlands., Joosten RP; Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Perrakis A; Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Olweus J; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Bassani-Sternberg M; Lausanne Branch, Ludwig Institute for Cancer Research, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Peeper DS; Division of Molecular Oncology and Immunology, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Agami R; Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. r.agami@nki.nl.; Erasmus MC, Department of Genetics, Rotterdam University, Rotterdam, The Netherlands. r.agami@nki.nl.
Publikováno v:
Nature [Nature] 2022 Mar; Vol. 603 (7902), pp. 721-727. Date of Electronic Publication: 2022 Mar 09.
Autor:
Champagne J; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Pataskar A; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Blommaert N; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Nagel R; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Wernaart D; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Ramalho S; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Kenski J; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Bleijerveld OB; Proteomics Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Zaal EA; Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, the Netherlands., Berkers CR; Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, the Netherlands., Altelaar M; Proteomics Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, the Netherlands., Peeper DS; Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Faller WJ; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Agami R; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands; Erasmus MC, Rotterdam University, Rotterdam, the Netherlands. Electronic address: r.agami@nki.nl.
Publikováno v:
Molecular cell [Mol Cell] 2021 Nov 18; Vol. 81 (22), pp. 4709-4721.e9. Date of Electronic Publication: 2021 Sep 24.
Autor:
Zheng, Zi‐Qi1 (AUTHOR), Zhong, Cheng‐Rui2 (AUTHOR), Wei, Cheng‐Zhi1 (AUTHOR), Chen, Xiao‐Jiang1 (AUTHOR), Chen, Guo‐Ming1 (AUTHOR), Nie, Run‐Cong1 (AUTHOR), Chen, Ze‐Wei1 (AUTHOR), Zhang, Fei‐Yang1 (AUTHOR), Li, Yuan‐Fang1 (AUTHOR), Zhou, Zhi‐Wei1 (AUTHOR) zhouzhw@sysucc.org.cn, Chen, Yong‐Ming1 (AUTHOR) chenyongm@sysucc.org.cn, Liang, Ye‐Lin3 (AUTHOR) liangyl@sysucc.org.cn
Publikováno v:
Advanced Science. 9/18/2024, Vol. 11 Issue 35, p1-16. 16p.
Autor:
Bartok O; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Pataskar A; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Nagel R; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Laos M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Goldfarb E; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Hayoun D; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Levy R; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Körner PR; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kreuger IZM; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Champagne J; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Zaal EA; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, The Netherlands.; Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands., Bleijerveld OB; Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Huang X; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kenski J; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Wargo J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Brandis A; Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Levin Y; The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel., Mizrahi O; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Alon M; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Lebon S; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Yang W; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Nielsen MM; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Stern-Ginossar N; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Altelaar M; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, The Netherlands.; Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Berkers CR; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, The Netherlands.; Department of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands., Geiger T; Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Peeper DS; Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Olweus J; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Samuels Y; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. Yardena.Samuels@weizmann.ac.il., Agami R; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. r.agami@nki.nl.; Erasmus MC, Rotterdam University, Rotterdam, The Netherlands. r.agami@nki.nl.
Publikováno v:
Nature [Nature] 2021 Feb; Vol. 590 (7845), pp. 332-337. Date of Electronic Publication: 2020 Dec 16.
Autor:
Mogos, Maria1,2,3 (AUTHOR) csocaciudac@gmail.com, Socaciu, Carmen3,4 (AUTHOR) sursoniu@umft.ro, Socaciu, Andreea Iulia5 (AUTHOR) andreeaiso@gmail.com, Vlad, Adrian2,3,6 (AUTHOR) jianu.dragos@umft.ro, Gadalean, Florica1,2,3 (AUTHOR) bob.flaviu@umft.ro, Bob, Flaviu1,2,3 (AUTHOR) milas.oana@umft.ro, Milas, Oana1,2,3 (AUTHOR) anca.simulescu@umft.ro, Cretu, Octavian Marius7,8 (AUTHOR) cretu.marius@umft.ro, Suteanu-Simulescu, Anca1,2,3 (AUTHOR) patruica.mihaela@umft.ro, Glavan, Mihaela1,2,3 (AUTHOR) lavinia.balint@umft.ro, Balint, Lavinia1,2,3 (AUTHOR) silvia-ioana.ienciu@umft.ro, Ienciu, Silvia1,2,3 (AUTHOR) iuliana.alioani@umft.ro, Iancu, Lavinia1,2,3 (AUTHOR) petrica.ligia@umft.ro, Jianu, Dragos Catalin2,3,9,10 (AUTHOR), Ursoniu, Sorin3,11,12 (AUTHOR), Petrica, Ligia1,2,3,10,11 (AUTHOR)
Publikováno v:
Journal of Clinical Medicine. Aug2024, Vol. 13 Issue 16, p4703. 14p.
Autor:
Emilius, Lisabeth1,2,3,4 (AUTHOR) lisabeth.emilius@fau.de, Bremm, Franziska1,2,3,4 (AUTHOR) franziska.bremm@uk-erlangen.de, Binder, Amanda Katharina1,2,3,4 (AUTHOR) amanda.binder@uk-erlangen.de, Schaft, Niels1,2,3,4 (AUTHOR) jan.doerrie@uk-erlangen.de, Dörrie, Jan1,2,3,4 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. May2024, Vol. 25 Issue 9, p4673. 37p.
Autor:
Savi, D. C., Haminiuk, C. W. I., Sora, G. T. S., Adamoski, D. M., Kenski, J., Winnischofer, S. M. B., Glienke, C.
Publikováno v:
International Journal of Pharmaceutical, Chemical & Biological Sciences; Jan-Mar2015, Vol. 5 Issue 1, p347-356, 10p
Autor:
Yokosawa, Takumi1 (AUTHOR), Wakasugi, Keisuke1,2,3 (AUTHOR) wakasugi@bio.c.u-tokyo.ac.jp
Publikováno v:
International Journal of Molecular Sciences. Oct2023, Vol. 24 Issue 20, p15453. 13p.